2nd Quarter - Report

THE SMITH-FREE GROUP, LLC for HCA

Firm
Client
HCA
Income
$130,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 1156 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) S 1133 Patient Access to Higher Quality Health Care Act of 2017 (all sections of full text) Discussions involving potential reform of health care delivery and payment systems implemented by The Affordable Care Act Discussions involving nominations to federally authorized commissions HR 277 American Health Care Reform Act of 2017 (all sections of full text) Discussions pertaining to the Better Care Reconciliation Act (BCRA), (all sections of full text) Monitored S 297 Increasing Competition in Pharmaceuticals Act Monitored HR 749 Lower Drug Costs through Competition Act Monitored S 1115 Making Pharmaceutical Markets More Competitive Act Monitored HR 208 Ensuring Health Care Opportunities Act Monitored discussions that would result in additional federal regulation of Group Purchasing Organizations Monitored Hatch/Senate Finance Committee examination of potential reforms to the Stark Law Monitored S 1115 Making Pharmaceutical Markets More Competitive Act Monitored HR 2562 Making Pharmaceutical Markets More Competitive Act Monitored S 191 Patient Freedom Act of 2017 Monitored S 761 Health Care Options Act of 2017 Monitored HR 1933 Health Care Options Act of 2017

LobbyistCovered position, as disclosed
JACK S DEUSER —
JAMES C FREE —
ROBERT HICKMOTT —
TREVOR W. KOLEGO —
W. TIMOTHY LOCKE —
SUMMER MERSINGER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 208 (115th), H.R. 277 (115th), H.R. 749 (115th), H.R. 1933 (115th), H.R. 2562 (115th), H.R. 1156 (115th)

Medicare/Medicaid MMM

Discussions pertaining to CMS IPPS Rule and Medicare DSH/S10 conversion Discussions pertaining to parity in insurance coverage for mental health and substance abuse Discussions involving effectiveness of telehealth technology in behavioral health care services Budget sequestration limits on Medicare spending Monitored HR 1130 Fair Medicare Hospital Payments Act of 2017 Monitored S 41 Medicare Prescription Drug Price Negotiation Act of 2017 Monitored HR 242 Medicare Prescription Drug Price Negotiation Act of 2017 Monitored S 260 Protecting Seniors' Access to Medicare Act of 2017 Monitored S 251 Protecting Medicare from Executive Action Act of 2017 Monitored HR 849 Protecting Seniors' Access to Medicare Act of 2017

LobbyistCovered position, as disclosed
JACK S DEUSER —
JAMES C FREE —
ROBERT HICKMOTT —
TREVOR W. KOLEGO —
W. TIMOTHY LOCKE —
SUMMER MERSINGER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 849 (115th), H.R. 1130 (115th), H.R. 242 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.